R2 lands distribution partner for Japan

Article

Mammography CAD developer R2 Technology of Los Altos, CA, has signed a product distribution deal with Marubeni America that gives Marubeni rights to sell its ImageChecker product in Japan. The deal extends for three years and is subject to minimum

Mammography CAD developer R2 Technology of Los Altos, CA, has signed a product distribution deal with Marubeni America that gives Marubeni rights to sell its ImageChecker product in Japan. The deal extends for three years and is subject to minimum purchase requirements. R2 executives believe that Japan will establish a national mammography screening program within the next two years, creating demand for ImageChecker.

In related news, R2 closed a $6 million round of venture financing last month, with Marubeni America and its parent firm, Marubeni Corp., joining with R2’s other financial backers in plowing more cash into the firm. R2 said it would use the money to finance its marketing efforts for ImageChecker in the U.S. and Japan.

© 1999 Miller Freeman, Inc.All rights reserved.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.